Clinical Trials Browser

Phase 2 × Recurrence × ruxolitinib × Clear all

NCT02974647 2026-04-22

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Phase 2 Recruiting

Lymphoma, Recurrence

NCT01965119 2018-11-01

JAK2

Phase 2 Completed

Hodgkin Disease, Recurrence